Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Flavonoid found in Rhus verniciflua and Butea m...
FIASMA, L-type Ca2+ channel blocker, D2 antagon...
Peptide hormone, neurotensin analog found in am...
Endogenous hormone and neurotransmitter involve...
D2/3 agonist.
Potential VEGFR2, Met, RET, Axl, Ron, PDGFR, FG...
Citalopram analog
β-lactam; penicillin binding protein inhibitor...
Flavonoid glycoside found in Pyrola.
Organosulfide found in Allium; cholesterol synt...
IGF-1R inhibitor.
Potential p53 activator or SIRT2 inhibitor.
Organosulfur, chelating agent.
MDM2 inhibitor.
Found in Cephalosporium; fatty acid synthase in...
Cephalotaxine alkaloid originally found in Ceph...
Neuroprotective flavonoid
Macrolide; F1F0 ATP synthase inhibitor.
β2-adrenergic agonist, BChE inhibitor.
5-fluorouracil prodrug, pyrimidine analog; thym...